CXCR4 and glioblastoma: These results confirm that the recurrence of glioblastoma after combined radio-chemotherapy is associated with an angiogenic switch in the pattern of chemokine expression to proangiogenic and protumoral CXCL12-CXCR4 pathway (Figure 3).